Cox regression analyses revealed a significantly improved survival on a univariate level (HR=0.709, 95% CI: 0.535-0.939, p = = 0.016), as well as an almost significant impact in combination with the standard prognostic covariates age, FIGO stage and residual tumor burden (HR=0.736, 95% CI: 0.535-1.011, p = = 0.059).
← all excerpts
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.
1
—
—